Blog

If you’ve ever had to navigate the prior authorization (PA) process in Canada, you know it can be time consuming and confusing. While PA plays an important role in ensuring the right medications are approved for the right patients, inefficiencies in the system create real challenges for all stakeholders—physicians, pharmacists, patient support, insurers, advisors, and most importantly, patients.

We need to do better, but how? When insurers, healthcare providers, advisors, and patients all have clear information about what’s required, how the process works, and there is consistency in practices and policies, then the claims process runs smoother.

Efforts to improve PA in Canada are taking place. There is agreement, including among payers, that the prior authorization process needs to be improved. Improvements will lead to a more efficient and effective system, better timelines for patients, and lower administration costs for payers and plan sponsors.

Why Transparency in Prior Authorization is Important

Whether it’s a paper based or electronic prior authorization (ePA) claims process, when healthcare providers and patients clearly understand the process it will reduce the administrative burden and the process will become more efficient.

A more transparent PA system should include:

• Clearly defined requirements: Insurers should provide accessible and detailed information about what documentation is needed for approval.
• Timely communication: Decisions should be communicated quickly to both healthcare providers and patients to minimize delays in treatment.
• Consistency in processes: Variability in PA requirements across different insurers creates confusion. Standardized workflows can reduce inefficiencies and errors.

Examples of Transparency in Canada

In Canada, prior authorization requirements vary between public and private payers. Ontario and British Columbia’s public drug programs provide detailed formularies and criteria for PA and have already adopted an ePA process.

The Ontario Drug Benefit (ODB) Exceptional Access Program (EAP), which provides detailed submission requirements for physicians, helps streamline the process and reduce unnecessary delays.

Similarly, the Workplace Safety and Insurance Board (WSIB) in Ontario publishes a list of requirements for PA drug submissions, ensuring prescribers and patients understand the expectations upfront.

Why Standardized PA Workflows Matter

A standardized approach to PA across Canada for both public and private payers could bring significant benefits:

• Reduced administrative burden: Physicians and pharmacists would spend less time navigating different insurer requirements.
• Faster decision-making: A streamlined process with clear expectations would reduce delays in care.
• Improved patient experience: Patients would have greater confidence in the system and could better plan for their treatment.

To provide a framework that reflects improvements payers can make, the Prior Authorization Framework and Accreditation (PAFA) Program was developed and launched in Fall 2024. It provides a common framework for claims administration and it provides an accreditation program for payers so that they can be recognized for achieving the Framework, whether it’s through their manual process or through the adoption of electronic prior authorization.

Looking Ahead

In whatever ways Canadian public and private payers choose to modernize PA processes, improving transparency, communication, and administration will be essential.

If you or your organization have experiences you would like to share with us, please reach out at the contact information below.